Event Abstract

Fluorescent core-shell alloy nanoparticles for cell targeting applications

  • 1 Polytechnique Montréal, Department of Engineering Physics, Canada
  • 2 Héma-Québec, Research and Development, Canada

Introduction: We report the synthesis and characterization of gold-silver (Au/Ag) alloy core silica shell (Au/Ag@SiO2) nanoparticles (NPs) incorporating fluorescent molecules and functionalized with antibodies (Abs) to target cancer cells (Fig. 1). These multifunctional Au/Ag@SiO2 NPs present various advantages: (1) The size of the Au/Ag core can produce tunable scattering signals due to local plasmonic resonance effect which can be easily collected by darkfield microscopy[1]; (2) The Abs-functionalized NPs can target cell surface receptors as contrast agent in flow cytometry (fluorescence and scattering channels)[2] due to high optical cross-section; (3) The field enhancement around the metallic core can increase the intensity of fluorescent molecules since they have a higher excitation and emission rate, generate more photons and are less vulnerable to photobleaching than unprotected fluorescent molecules[3]-[5]; (4) The combination of multiple NPs displaying characteristics signals in both darkfield and fluorescence channels can bring a significant improvement in terms of marker efficiency; (5) The SiO2 shell should allow the incorporation and protection of a high number of fluorescent molecules and further ease the surface modification.

Material and Methods: Fluorescent molecules (Fluorescein isothiocyanate (FITC), Rhodamine B isothiocyanate (RBITC) and CF 647) were incorporated in the SiO2 shell after reaction with (3-aminopropyl)triethoxysilane (APTES) diluted with dimethylformamide (DMF) and triethylamine (as a catalyst) to form fluorescent precursors (FPs). Au/Ag@SiO2 NPs were synthesized with tetraethyl orthosilicate (TEOS), ammonia solution, FPs and 60 nm citrate-capped (25/75 or 50/50) Au/Ag alloy NPs diluted in EtOH under continuous stirring for 24 h. Au/Ag@SiO2 surface was modified with (3-mercaptopropyl)trimethoxysilane (MPTMS) to react with Abs (anti-CD44 and anti-EGFR as positive Abs, anti-Nectin2 as negative Abs) in presence of sulfosuccinimidyl 4-(N-maleimidomethyl)cyclohexane-1-carboxylate (sulfo-SMCC). Functionalized NPs were incubated with human HeLa cancer cells for 30 minutes in dark environment on ice.

Results and Discussion: Fluorescent tunable Au/Ag@SiO2 NPs have been synthesized and characterized (Fig. 2). NPs containing 60 nm Au/Ag (25/75 or 50/50)[6] have been produced and visualized by TEM (Fig. 2A,B) since their different scattering peaks can be used in darkfield microscopy. The fluorescent molecules incorporated in the NPs showed clear signal compared to bare Au/Ag NPs and supernatant (Fig. 2C-E). Au/Ag@SiO2 NPs containing FITC were then observed by darkfield and fluorescence microscopy (Fig. 2F,G). The scattering and fluorescent signals colocalized and the higher scattering intensity of NP clusters colocalized with brighter fluorescent signal. The fluorescent NPs targeting cancer cells was confirmed by flow cytometry (Fig. 3).

Conclusion: Fluorescent Au/Ag@SiO2 NPs targeting different cell surface receptors were synthesized, characterized and used as contrast agent labeling cancer cells. The combination of scattering and fluorescence channels in flow cytometry from the proposed NPs incorporating different fluorescent molecules would allow multifunctional and multichromatic possibilities for in vitro and in vivo imaging.

This work was supported by Le Fonds de recherche du Québec and the Natural Science and Engineering Research Council of Canada. ST received funding from MEDITIS.

References:
[1] Patskovsky, S., Bergeron, E., Rioux, D., Simard, M., & Meunier, M. (2014). Hyperspectral reflected light microscopy of plasmonic Au/Ag alloy nanoparticles incubated as multiplex chromatic biomarkers with cancer cells. Analyst, 139(20), 5247-5253.
[2] Brouard, D., Viger, M. L., Bracamonte, A. G., & Boudreau, D. (2011). Label-free biosensing based on multilayer fluorescent nanocomposites and a cationic polymeric transducer. Acs Nano, 5(3), 1888-1896.
[3] Aslan, K., Wu, M., Lakowicz, J. R., & Geddes, C. D. (2007). Fluorescent core-shell Ag@ SiO2 nanocomposites for metal-enhanced fluorescence and single nanoparticle sensing platforms. Journal of the American Chemical Society, 129(6), 1524-1525.
[4] Kang, D., Lim, H., Kim, C., Song, I., Park, J., Park, Y., & Chung, J. (2007). Amorphous gallium indium zinc oxide thin film transistors: Sensitive to oxygen molecules. Applied physics letters, 90(19), 192101.
[5] Tang, F., He, F., Cheng, H., & Li, L. (2010). Self-assembly of conjugated polymer-Ag@ SiO2 hybrid fluorescent nanoparticles for application to cellular imaging. Langmuir, 26(14), 11774-11778.
[6] D. Rioux and M. Meunier (2014) Alloy nanoparticles, process for their preparation and use thereof, USPTO61945276.

Keywords: contrast agent, nanoparticle, biofunctionalization, Imaging method

Conference: 10th World Biomaterials Congress, Montréal, Canada, 17 May - 22 May, 2016.

Presentation Type: Poster

Topic: Imaging with biomaterials

Citation: Tu S, Brouard D, Perreault J, Bergeron E, Rioux D and Meunier M (2016). Fluorescent core-shell alloy nanoparticles for cell targeting applications. Front. Bioeng. Biotechnol. Conference Abstract: 10th World Biomaterials Congress. doi: 10.3389/conf.FBIOE.2016.01.02194

Copyright: The abstracts in this collection have not been subject to any Frontiers peer review or checks, and are not endorsed by Frontiers. They are made available through the Frontiers publishing platform as a service to conference organizers and presenters.

The copyright in the individual abstracts is owned by the author of each abstract or his/her employer unless otherwise stated.

Each abstract, as well as the collection of abstracts, are published under a Creative Commons CC-BY 4.0 (attribution) licence (https://creativecommons.org/licenses/by/4.0/) and may thus be reproduced, translated, adapted and be the subject of derivative works provided the authors and Frontiers are attributed.

For Frontiers’ terms and conditions please see https://www.frontiersin.org/legal/terms-and-conditions.

Received: 27 Mar 2016; Published Online: 30 Mar 2016.